Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: Pediatr Blood Cancer. 2023 Mar 21;70(6):e30288. doi: 10.1002/pbc.30288

Table 2.

Mobile Application Rating Scale (MARS) scores (Phase 1 – clinicians and parents)

MARS scores
Domain Clinicians (MARS) N=14 Parents (uMARS) N=8 Combined Scores N=22
Mean±SD Median (range) Mean±SD Median (range) Mean±SD Median (range)
Engagement 4.3±0.7 4 (2–5) 4.3±0.6 4 (3–5) 4.3±0.7 4 (2–5)
Functionality 4.5±0.5 5 (4–5) 4.7±0.5 5 (4–5) 4.6±0.5 5 (4–5)
Aesthetics 4.5±0.6 5 (3–5) 4.5±0.6 5 (3–5) 4.5±0.6 5 (3–5)
Information 4.7±0.5 5 (4–5) 4.8±0.4 5 (4–5) 4.8±0.4 5 (4–5)
Subjective quality 4.2±1.0 4 (1–5) 4.3±0.7 4 (3–5) 4.2±0.9 4 (1–5)
Perceived impact 4.6±0.5 5 (4–5) N/A* N/A* 4.6±0.5 5 (4–5)
Overall rating 4.5±0.7 5 (1–5) 4.5±0.6 5 (3–5) 4.5±0.7 5 (1–5)
*

Perceived impact is rated only by clinicians

There was no statistically significant difference between mean MARS scores for clinicians compared to parents

Abbreviations: MARS = Mobile Application Rating Scale; uMARS = end-user version of the Mobile Application Rating Scale; SD=Standard deviation; N/A=Not applicable